Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional paid-in capital	Accumulated deficit	Accumulated OCI	Total
Balance at the beginning at Dec. 31, 2024	$ 18	$ 591,394	$ (181,171)	$ 39	$ 410,280
Balance at the beginning (in shares) at Dec. 31, 2024	180,364,028
Changes in stockholder's equity
Net loss			(15,151)		(15,151)
Withholding of employee taxes related to stock-based compensation		(261)			(261)
Shares of common stock issued for vested RSUs (in Shares)	551,828
Stock options exercised		181			181
Stock options exercised (in shares)	1,532,420
Remeasurement of mezzanine equity			20		20
Unrealized gain on available-for-sale securities				173	173
Stock-based compensation expense		1,830			1,830
Balance at the end at Mar. 31, 2025	$ 18	593,144	(196,302)	212	397,072
Balance at the end (in shares) at Mar. 31, 2025	182,448,276
Balance at the beginning at Dec. 31, 2025	$ 20	690,234	(274,904)	354	415,704
Balance at the beginning (in shares) at Dec. 31, 2025	201,181,175
Changes in stockholder's equity
Net loss			(13,028)		(13,028)
Withholding of employee taxes related to stock-based compensation		(358)			(358)
Shares of common stock issued for vested RSUs (in Shares)	488,734
Stock options exercised		6			$ 6
Stock options exercised (in shares)	42,494				42,494
Remeasurement of mezzanine equity			97		$ 97
Unrealized gain on available-for-sale securities				(1,407)	(1,407)
Proceeds from the registered direct offering, net of offering costs, commissions, and fees of $8,664	$ 2	121,334			121,336
Proceeds from the registered direct offering, net of offering costs, commissions, and fees of $8,664 (in shares)	22,807,018
Stock-based compensation expense		2,706			2,706
Balance at the end at Mar. 31, 2026	$ 22	$ 813,922	$ (287,835)	$ (1,053)	$ 525,056
Balance at the end (in shares) at Mar. 31, 2026	224,519,421